Results 21 to 30 of about 63,312 (252)
Mesothelioma in Scotland [PDF]
BMJ, 1970 In a retrospective study of the incidence of mesothelioma in Scotland for 1950-67 80 cases were traced from pathological reports and biopsy material of malignant tumours invading the pleura and peritoneum. These cases were matched with two sets of controls.
J, McEwen +3 more
openaire +2 more sources
Orphanet Journal of Rare Diseases, 2008 Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis. The exact prevalence is unknown but it is estimated that mesotheliomas represent less than 1% of all cancers.
Parker Robert J +2 more
openaire +3 more sources
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG
Antioxidants, 2020 The expression of pluripotency factors is a key regulator of tumor differentiation status and cancer stem cells. The purpose of this study was to examine the expression of pluripotency factors and differentiation status of human mesothelioma and the role
Filip Sedlic +8 more
doaj +1 more source
Understanding clinical decision-making in mesothelioma care: a mixed methods study
BMJ Open Respiratory Research, 2022 Introduction Malignant pleural mesothelioma is a rare, incurable cancer arising from previous asbestos exposure; patients have a poor prognosis, with a median survival rate of 8–14 months. Variation in mesothelioma clinical decision-making remains common
Najib Rahman +9 more
doaj +1 more source
Meet the researchers: an alternative method of engaging patients with research in mesothelioma
Research Involvement and Engagement, 2018 Plain English summary There are new ways to engage people with science and research but many patient support groups and charitable organisations still hold traditional meetings to provide updates on their activities and to report new developments in ...
Kate Hill, Mags Portman, Zsuzsanna Tabi
doaj +1 more source
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. [PDF]
PLoS ONE, 2017 Malignant mesothelioma is a malignant tumor on the pleura or the peritoneum caused mostly by asbestos. Although asbestos is not currently used in South Korea, the incidence of mesothelioma is increasing due to its long latent period. This study predicted
Kyeong Min Kwak +3 more
doaj +1 more source
The role of CD24 as a potential biomarker for malignant pleural mesothelioma
Egyptian Journal of Chest Disease and Tuberculosis, 2023 Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa +4 more
doaj +1 more source
BMJ Open, 2021 Objectives The study aim was to explore experiences of patients with pleural mesothelioma of follow-up care in three National Health Service (NHS) Trusts to develop recommendations for practice.Design The study design was qualitative and comprised three ...
Najib Rahman +6 more
doaj +1 more source
Environmental Asbestos Exposure as a Possible Pathway to Early-Onset Pleural Mesothelioma: A Case From Afghanistan and Pakistan to London. [PDF]
Respirol Case RepWe report a case of a 40‐year‐old male with malignant pleural mesothelioma with no prior occupational exposure to asbestos. Environmental exposure as a cause of MPM may come into focus through migration from high environmental asbestos exposure regions in patients with no known occupational exposure.
Mounouchos S +5 more
europepmc +2 more sources
Malignant Peritoneal Mesothelioma Diagnosed by a Laparoscopy : A Case Report [PDF]
, 2023 Malignant mesothelioma is rare, and its prognosis is markedly poor. It is often difficult to distinguish malignant mesothelioma from carcinomatous peritonitis of other solid tumors.
品川, 真奈花 +10 more
core +1 more source